![Michael Kalos](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Kalos
Director/Miembro de la Junta en IMV INC. .
Fortuna: - $ al 31/12/2023
Perfil
Michael Kalos is an Independent Director at IMV, Inc. and a Managing Director at Next Pillar Consulting, LLC.
He was formerly the Chief Scientific Officer at Eli Lilly & Co., the Vice President-Immunooncology at Janssen Pharmaceuticals, Inc., and the Executive VP & Head-Research & Development at Arsenal Biosciences, Inc. He holds a doctorate degree from the University of Minnesota.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
IMV INC.
-.--% | 31/03/2023 | 0 ( -.--% ) | - $ | 31/12/2023 |
Cargos activos de Michael Kalos
Empresas | Cargo | Inicio |
---|---|---|
IMV INC. | Director/Miembro de la Junta | 11/05/2021 |
Next Pillar Consulting, LLC | Director Ejecutivo | - |
Antiguos cargos conocidos de Michael Kalos.
Empresas | Cargo | Fin |
---|---|---|
Janssen Pharmaceuticals, Inc.
![]() Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Corporate Officer/Principal | - |
ELI LILLY AND COMPANY | Director Técnico/Científico/I+D | - |
Arsenal Biosciences, Inc.
![]() Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Arsenal Biosciences, Inc. discovers, develops, and commercializes curative immune cell therapies. It offers cell therapy, cloud computing, computational biology, genome engineering, machine learning, software engineering, and synthetic immunology. The company was founded by Ken E. Drazan, Bradley E. Bernstein, W. Nicholas Haining, Theo Roth, Kole T. Roybal, and E. John Wherry and is headquartered in San Francisco, CA. | Director Técnico/Científico/I+D | - |
Formación de Michael Kalos.
University of Minnesota | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
IMV INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Janssen Pharmaceuticals, Inc.
![]() Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Arsenal Biosciences, Inc.
![]() Arsenal Biosciences, Inc. Packaged SoftwareTechnology Services Arsenal Biosciences, Inc. discovers, develops, and commercializes curative immune cell therapies. It offers cell therapy, cloud computing, computational biology, genome engineering, machine learning, software engineering, and synthetic immunology. The company was founded by Ken E. Drazan, Bradley E. Bernstein, W. Nicholas Haining, Theo Roth, Kole T. Roybal, and E. John Wherry and is headquartered in San Francisco, CA. | Technology Services |
Next Pillar Consulting, LLC |
- Bolsa de valores
- Insiders
- Michael Kalos